EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Potential of Metabolomics in Colorectal Cancer Prognosis

Chengqu Fu, Xinyi Liu, Le Wang, Dong Hang iD

Metabolites · 15.12.2024 · 14 (12) · 708

DOI: 10.3390/metabo14120708 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 15.12.2024. Verfasst von Chengqu Fu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative, Innovation Center for Cancer Personalized …. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund for Excellent Young Scholars, Outstanding Youth Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is one of the most common cancers worldwide, posing a serious threat to human health. Metabolic reprogramming represents a critical feature in the process of tumor development and progression, encompassing alterations in sugar metabolism, lipid metabolism, amino acid metabolism, and other pathways. Metabolites hold promise as innovative prognostic biomarkers for cancer patients, which is crucial for targeted follow-up care and interventions. This review aims to provide an overview of the progress in research on metabolic biomarkers for predicting the prognosis of CRC. We also discuss the future trends and challenges in this area.

Schlagwörter

Stichwörter der Autor:innen

biomarkercolorectal cancermetabolomicsprognosis

Autor:innen und Institutionen

  • Department of Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative, Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing…
  • Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China.
  • Changzhou Medical Center, Nanjing Medical University, Changzhou 213000, China.

ORCID-Profile: Dong Hang

Förderung

  • National Science Fund for Excellent Young Scholars
  • Outstanding Youth Foundation of Jiangsu Province

Zitieren

APA

Fu, C., Liu, X., Wang, L., & Hang, D. (2024). The Potential of Metabolomics in Colorectal Cancer Prognosis. Metabolites, 14(12), 708. https://doi.org/10.3390/metabo14120708

Vancouver

Fu C, Liu X, Wang L, Hang D. The Potential of Metabolomics in Colorectal Cancer Prognosis. Metabolites. 2024;14(12):708. doi:10.3390/metabo14120708

BibTeX
@article{Fu2024,
  author = {Fu, Chengqu and Liu, Xinyi and Wang, Le and Hang, Dong},
  title = {The Potential of Metabolomics in Colorectal Cancer Prognosis},
  journal = {Metabolites},
  year = {2024},
  volume = {14},
  number = {12},
  pages = {708},
  doi = {10.3390/metabo14120708}
}
Kostenlos starten →